Dailypharm Live Search Close

Exclusive domestic sales of JW Shinyak, Galderma hair loss

By | translator Kim, Jung-Ju

23.03.15 09:54:56

°¡³ª´Ù¶ó 0
Supply Ell-cranell, hair loss medicine, Loceryl nail lacquer, athlete's foot medicine


 ¡ãKim Yong-gwan, CEO of JW Shinyak (right), and Kim Yeon-hee, CEO of Galderma

JW Shinyak announced on the 15th that it has signed a domestic exclusive sales contract with Galderma for hair loss treatment Ell-cranell and nail athlete's foot treatment Loceryl nail lacquer. According to the contract, JW Shinyak will be in charge of domestic sales and marketing of the two products. Ell-cranell is an androgenetic alopecia treatment that can be used by both men and women. It minimizes hair loss by suppressing the production of dihydrotestosterone, which is the cause of hair loss, threefold. It is easy to apply to the scalp with an applicator once a day, increasing convenience.

As a result of clinical trials on 51 female patients with androgenetic alopecia in Korea, the number of hair i

(same@dailypharm.com)
If you want to see the full article, please JOIN US (click)